AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 MAY 16 - (NewsRx.com & NewsRx.net) -- Unigene Laboratories, Inc., (UGNE) announced that it expects sales of injectable calcitonin by its joint venture with the Shijiazhuang Pharmaceutical Group to commence on April 1, 2002.
The joint venture will promote and sell the product in China for the treatment of osteoporosis. In addition to recognizing revenue on any sales of bulk calcitonin by Unigene to the joint venture, Unigene will be entitled to 45% of any profits achieved by the joint venture.
Unigene's approval in Switzerland for its injectable calcitonin product ...